Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Egesta Lopci

Showing results (21-30 of 198) with videos related to

Pageof 20
Sort By:
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|February 29, 2020
Cancer management in the era of immunotherapy: much more than meets the eyeEgesta Lopci, John B Haanen
European Radiology|March 13, 2026
Letter to the Editor: "Less is better" does not suit all cases in colon cancer imagingAnna Margherita Maffione, Egesta Lopci
BJU International|February 21, 2019
Prostate cancer imaging and therapeutic alternatives with highly specific molecular 'probes'Egesta Lopci, Arnoldo Piccardo, Massimo Lazzeri
Seminars in Nuclear Medicine|August 14, 2022
FDG PET/CT for Staging and Restaging Malignant MesotheliomaEgesta Lopci, Angelo Castello, Luigi Mansi
Revista Espanola De Medicina Nuclear E Imagen Molecular|July 5, 2021
Peritoneal carcinomatosis and occult metastasis in prostate cancer: [<sup>68</sup>Ga]PSMA vs [<sup>11</sup>C]CholineAngelo Castello, Paola Caroli, Egesta Lopci
Seminars in Nuclear Medicine|November 11, 2023
PSMA PET/CT Versus mpMRI for the Detection of Clinically Significant Prostate Cancer: An Updated OverviewMatteo Caracciolo, Angelo Castello, Egesta Lopci
European Urology|March 30, 2016
Re: Laura Evangelista, Alberto Briganti, Stefano Fanti, et al. New Clinical Indications for <sup>18</sup>F/<sup>11</sup>C-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the Literature. Eur Urol 2016;70:161-75Egesta Lopci, Arturo Chiti, Massimo Lazzeri
Current Radiopharmaceuticals|December 31, 2019
18F-FDG PET/CT in Restaging and Evaluation of Response to Therapy in Lung Cancer: State of the ArtAngelo Castello, Sabrina Rossi, Egesta Lopci
American Journal of Nuclear Medicine and Molecular Imaging|March 14, 2018
Adenoid cystic carcinoma: focus on heavy ion therapy and molecular imagingAngelo Castello, Laura Olivari, Egesta Lopci
Cancer Biotherapy & Radiopharmaceuticals|February 2, 2023
Novelties from the Joint EANM/SNMMI/ANZSNM Guidelines on ImmunotherapyEgesta Lopci, Angelo Castello, Luca Filippi
Pageof 20

Showing results (21-30 of 198) with videos related to

Sort By:
Pageof 20
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|February 29, 2020
Cancer management in the era of immunotherapy: much more than meets the eyeEgesta Lopci, John B Haanen
European Radiology|March 13, 2026
Letter to the Editor: "Less is better" does not suit all cases in colon cancer imagingAnna Margherita Maffione, Egesta Lopci
BJU International|February 21, 2019
Prostate cancer imaging and therapeutic alternatives with highly specific molecular 'probes'Egesta Lopci, Arnoldo Piccardo, Massimo Lazzeri
Seminars in Nuclear Medicine|August 14, 2022
FDG PET/CT for Staging and Restaging Malignant MesotheliomaEgesta Lopci, Angelo Castello, Luigi Mansi
Revista Espanola De Medicina Nuclear E Imagen Molecular|July 5, 2021
Peritoneal carcinomatosis and occult metastasis in prostate cancer: [<sup>68</sup>Ga]PSMA vs [<sup>11</sup>C]CholineAngelo Castello, Paola Caroli, Egesta Lopci
Seminars in Nuclear Medicine|November 11, 2023
PSMA PET/CT Versus mpMRI for the Detection of Clinically Significant Prostate Cancer: An Updated OverviewMatteo Caracciolo, Angelo Castello, Egesta Lopci
European Urology|March 30, 2016
Re: Laura Evangelista, Alberto Briganti, Stefano Fanti, et al. New Clinical Indications for <sup>18</sup>F/<sup>11</sup>C-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the Literature. Eur Urol 2016;70:161-75Egesta Lopci, Arturo Chiti, Massimo Lazzeri
Current Radiopharmaceuticals|December 31, 2019
18F-FDG PET/CT in Restaging and Evaluation of Response to Therapy in Lung Cancer: State of the ArtAngelo Castello, Sabrina Rossi, Egesta Lopci
American Journal of Nuclear Medicine and Molecular Imaging|March 14, 2018
Adenoid cystic carcinoma: focus on heavy ion therapy and molecular imagingAngelo Castello, Laura Olivari, Egesta Lopci
Cancer Biotherapy & Radiopharmaceuticals|February 2, 2023
Novelties from the Joint EANM/SNMMI/ANZSNM Guidelines on ImmunotherapyEgesta Lopci, Angelo Castello, Luca Filippi
Pageof 20